NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ), a leading biotechnology company specializing in gene identification and genetic and immune regulation technologies for diagnostic and therapeutic applications, announced today that it has appointed Christine T. Fischette, Ph.D., President of its wholly-owned Enzo Therapeutics subsidiary.
